PROVIDENCE – Three out of seven hopeful innovators received encouragement during a recent pitch night hosted by Cherrystone Angel Group.
Seven early-stage ventures, including health care devices and innovative construction materials, were presented to 120 Cherrystone Angel Group investors and guests at District Hall in Providence. Pitches were evaluated for possible investment by Cherrystone members.
Three ventures were chosen for further investment consideration:
- Vitae, a producer of personalized medication for precision medicine using 3D printing technology.
- My Moc, a supplier of a customized, personal digital library for state licensing and board certification requirements and continuing medical education.
- CathBuddy, a developer of a reusable catheter system to reduce urinary tract infection and improve the standard of care for individuals who use intermittent urinary catheters.
Sponsors for Venture Pitch Night were Foley Hoag, Duffy & Sweeney Ltd., DiSanto Priest & Co., Adler Pollock & Sheehan, Brown Biotechnology Graduate Program, and Marcum LLP, doing business as Marcum Accountants & Advisors.
Founded in 2004, Cherrystone Angel Group offers early-stage investment funds to companies in need of capital growth, primarily in New England.
Mary Lhowe is a PBN contributing writer.
Want to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.